Carbonic anhydrases in meningiomas: association of endothelial carbonic anhydrase II with aggressive tumor features.

@article{Korhonen2009CarbonicAI,
  title={Carbonic anhydrases in meningiomas: association of endothelial carbonic anhydrase II with aggressive tumor features.},
  author={Katariina Korhonen and Anna Kaisa Parkkila and Pauli Hel{\'e}n and Ritva V{\"a}lim{\"a}ki and Silvia Pastorekov{\'a} and Jarom{\'i}r Pastorek and Seppo Parkkila and Hannu K Haapasalo},
  journal={Journal of neurosurgery},
  year={2009},
  volume={111 3},
  pages={
          472-7
        }
}
OBJECT Carbonic anhydrase (CA) II and IX are enzymes involved in pH homeostasis and have been shown to be upregulated in several types of cancer. In this study, the authors evaluate the expression of CA II and IX in meningiomas and assess their relationship to patient age, tumor type and grade, tumor sex hormone receptor status, tumor cell proliferation, and tumor recurrence. METHODS This study was conducted in consecutive patients who underwent meningioma surgeries at Tampere University… 
The Expression of Carbonic Anhydrases II, IX and XII in Brain Tumors
TLDR
Their role in tumorigenesis and potential value in predicting prognosis of brain tumors, including astrocytomas, oligodendrogliomas, ependymomas, medulloblastomas, meningiomas, and craniopharyngiomas are reviewed.
Meningiomas: Role of Carbonic Anhydrase II
TLDR
Only minority of meningiomas express CA II but expression is associated with cell proliferation and tumor malignancy grade, thus, CA II expression may be associated with malignant progression of meniomas.
Carbonic Anhydrase IX in Adult and Pediatric Brain Tumors
TLDR
Carbonic anhydrases, zinc-containing metalloenzymes present in prokaryotes and eukaryotes, are important in normal human physiology and can be categorized to catalytically active or inactive, intracellular or extracellular, and wide-spread or restricted to few tissues.
Carbonic anhydrase 2 (CAII) supports tumor blood endothelial cell survival under lactic acidosis in the tumor microenvironment
TLDR
The present study shows that, unlike NECs, TECs proliferate in lactic acidic, suggesting that due to their effect on blood vessel maturity, pH regulators like CAII are promising targets of antiangiogenic therapy.
Carbonic anhydrases II and XII are up-regulated in osteoclast-like cells in advanced human atherosclerotic plaques—Tampere Vascular Study
TLDR
Evidence is provided for the involvement of CAs in advanced atherosclerosis in osteoclast-like cells of monocyte-macrophage lineage in atherosclerotic plaques using immunohistochemistry and double-staining immunofluorescence analysis.
Carbonic anhydrase IX, a hypoxia-induced catalytic component of the pH regulating machinery in tumors
TLDR
The view that CA IX is a biologically and clinically relevant molecule, exploitable in anticancer strategies aimed at targeting adaptive responses to hypoxia and/or acidosis, is supported by numerous clinical studies demonstrating the association of CA IX with various clinical correlates and markers of aggressive tumor behavior.
Predicting outcomes of patients with intracranial meningiomas using molecular markers of hypoxia, vascularity, and proliferation.
TLDR
HIF, VEGF, and MIB-1 are significantly correlated with tumor recurrence and may be used to predict outcome for patients with intracranial meningiomas.
CA II, a potential biomarker by proteomic analysis, exerts significant inhibitory effect on the growth of colorectal cancer cells.
In the Western world, colorectal cancer (CRC) is the third most common cancer with poor prognosis. To identify the proteins and to elucidate the possible mechanisms involved in colorectal
...
1
2
...

References

SHOWING 1-10 OF 39 REFERENCES
Expression of Carbonic Anhydrase IX in Astrocytic Tumors Predicts Poor Prognosis
TLDR
The results suggest that CA IX is a useful biomarker for predicting poor prognosis of astrocytic tumors and may also be a promising target molecule for the improvement of therapeutic interventions inAstrocytomas.
Carbonic anhydrase II in the endothelium of glial tumors: a potential target for therapy.
TLDR
Investigation of endothelial CA II expression in two types of brain cancer found that it may play an important functional role in tumor metabolism, and opens new avenues for selecting tumor types for dendritic cell therapy trials.
Expression of the hypoxia marker carbonic anhydrase 9 is associated with anaplastic phenotypes in meningiomas.
  • H. Yoo, G. Baía, +5 authors A. Lal
  • Medicine
    Clinical cancer research : an official journal of the American Association for Cancer Research
  • 2007
TLDR
Tumor hypoxia is an endogenous feature of meningiomas, and therapeutic regimens should include strategies to target the subpopulation of hypoxic as well as the normoxic cells within the tumor.
Immunohistochemical demonstration of the carbonic anhydrase isoenzymes I and II in pancreatic tumours
TLDR
The normal and malignant endocrine tissue showed intense positive staining for CA I localized in the cells expressing glucagon, and in the exocrine pancreatic tissue, CA II was detected in the normal and neoplastic ductal epithelium.
Carbonic anhydrase IX, a marker of hypoxia: correlation with clinical outcome in transitional cell carcinoma of the bladder.
TLDR
There was a trend towards longer survival for tumour expressing CA IX strongly and this is likely to be a reflection of the significantly higher rate of strong CA IX expression in non-invasive cancers influencing these survival data.
The expression of carbonic anhydrase II in hematological malignancies.
TLDR
Investigation of the presence of CA isozymes in six malignant hematopoietic cell lines and malignant blast cells of bone marrow samples collected from patients with acute myeloid leukemia, acute lymphoblastic leukemia, or chronic myelomonocytic leukemia indicates that CA II expression is not restricted to only one cell lineage but may result from a genetic aberration that occurs in both myeloids and lymphatic lineages.
Immunohistochemical demonstration of human carbonic anhydrase isoenzyme II in brain tumours
TLDR
The present results demonstrate that despite the malignant transformation of the cells, the expression of CA II is sustained in astrocytic tumours, oligodendrogliomas, ependymal and choroid plexus tumours and tumours of nerve sheath cell origin.
Expression of carbonic anhydrase I or II and correlation to clinical aspects of colorectal cancer.
TLDR
The expressions ofcarbonic anhydrase I and II correlated with biological aggressiveness of colorectal cancer and synchronous distant metastasis, especially carbonic anHydrase I for colon cancer and carbonicAnhydrase II for rectal cancer.
Carbonic Anhydrase II Is a Tumor Vessel Endothelium–Associated Antigen Targeted by Dendritic Cell Therapy
TLDR
It is suggested that CA-II is a tumor vessel endothelium–associated antigen in melanoma and other cancers, and elicitation of serum anti–CA-II antibody by dendritic cell therapy may be associated with good clinical outcome including tumor reduction.
Prognostic significance of a novel hypoxia-regulated marker, carbonic anhydrase IX, in invasive breast carcinoma.
  • S. Chia, C. Wykoff, +6 authors A. Harris
  • Biology, Medicine
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • 2001
TLDR
CA IX expression was associated with worse relapse-free survival and overall survival in an unselected cohort of patients with invasive breast carcinoma, and the potential role of CA IX as a marker of hypoxia within breast carcinomas was also indicated by a significant association with necrosis.
...
1
2
3
4
...